Recalls & Warnings
ConsumerLab.com is keeping you informed with current product recalls and warnings.
Posted March 27, 2014
Three Weight Loss Supplements Containing Drugs Recalled
Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.
Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."
Super Fat Burner, Maxi Gold and Esmeralda are packaged in 30-capsule bottles and were promoted for weight loss. They were sold in NY, NJ, LA, TX, VA, and MA in retail stores and through the internet at the company's website www.newlifenutritional.com.
Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.
(See ConsumerLab.com's Review of Weight Loss Supplements for tests of related products.)
See Related Warnings:
For more about this recall, use the link below.